Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
36,42 USD | +1,62% | +4,54% | +18,32% |
11/04 | Collegium Pharmaceutical riscatterà 26,35 milioni di dollari di note senior | MT |
26/02 | COLLEGIUM PHARMACEUTICAL, INC. : Piper Sandler rimane Buy | ZM |
Attività
Numero di dipendenti: 197
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 464 | 100,0 % | 567 | 100,0 % | +22,17% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 464 | 100,0 % | 567 | 100,0 % | +22,17% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Founder | 59 | 01/01/02 | |
Joseph Ciaffoni
CEO | Chief Executive Officer | 53 | 31/05/17 |
Colleen Tupper
DFI | Director of Finance/CFO | 48 | 24/05/21 |
Scott Sudduth
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/18 |
Shirley Kuhlmann
ADM | Chief Administrative Officer | 40 | 16/03/18 |
Thomas Smith
CTO | Chief Tech/Sci/R&D Officer | 63 | 23/03/22 |
Investor Relations Contact | - | 01/01/23 | |
Kelly Clements
HRO | Human Resources Officer | - | 01/05/22 |
Scott Dreyer
PRN | Corporate Officer/Principal | 52 | 01/01/18 |
Arun Padmanabhan
SAM | Sales & Marketing | - | 01/10/17 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Garen Bohlin
BRD | Director/Board Member | 76 | 01/01/15 |
Gino Santini
BRD | Director/Board Member | 66 | 24/07/12 |
John Freund
BRD | Director/Board Member | 70 | 01/02/14 |
Joseph Ciaffoni
CEO | Chief Executive Officer | 53 | 31/05/17 |
Gwen Melincoff
BRD | Director/Board Member | 72 | 09/08/17 |
Founder | 59 | 01/01/02 | |
John Fallon
BRD | Director/Board Member | 76 | 13/06/16 |
Neil McFarlane
BRD | Director/Board Member | 51 | 06/04/22 |
Director/Board Member | 63 | 24/09/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 39 029 639 | 32 245 170 ( 82,62 %) | 6 323 892 ( 16,20 %) | 82,62 % |
Coordinate società
Collegium Pharmaceutical, Inc.
100 Technology Center Drive Suite 300
02072, Stoughton
+781 713 3699
http://www.collegiumpharma.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+18,32% | 1,19 Mrd | |
+25,83% | 661 Mrd | |
+27,00% | 566 Mrd | |
-6,76% | 352 Mrd | |
+20,34% | 332 Mrd | |
+3,00% | 283 Mrd | |
+13,09% | 231 Mrd | |
+5,46% | 200 Mrd | |
-9,61% | 195 Mrd | |
-6,26% | 145 Mrd |
- Borsa valori
- Azioni
- Azione COLL
- Società Collegium Pharmaceutical, Inc.